Market Research Logo

The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)


This  Kalorama Information report  The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment.

Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI.   Treatment and testing guidelines for the following diseases are covered:

Acinetobacter Baumannii Clostridium Difficile Hospital-Acquired Pneumonia Pseudomonas Aeruginosa Staphylococcus Aureus Methicillin-resistant Staphylococcus Aureus (MRSA) Vancomycin-Intermediate/Resistant Staphylococcus Aureus Tuberculosis Urinary Tract Infections Vancomycin-resistant Enterococcus Ventilator-Associated Pneumonia
Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions. This has created a market opportunity for companies that can test for, treat and help prevent these infections.

Fighting the scourge of HAIs requires a multi-faceted approach.  The report will provide a market analysis for each of the three areas:

Prevention (Medical Device/Instrument Sterilization, Wide-Area Sterilization, Other)
 Testing Markets for HAI (C.Diff, MRSA, Other)
Treatment Markets


For each segment, the report breaks out the market by major regions (United States, Europe, ROW) and the emerging markets.  The infection control market is a stable one for companies involved in these areas. As long as there are infections there will always be a need for controlling these infections. It is a fact that diseases evolve and that new approaches to preventing, diagnosing and treating will be required for the long-term.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.

The majority of competitive participation for Hospital-Acquired Infection control and is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. Companies included in this report are:

    Advanced Sterilization Products
    Becton Dickinson
    Belimed AG
    bioMerieux
    Cantel
    Cepheid
    Getinge
    Kimberly-Clark
    Merck & Co.
    Nordion
    Pfizer
    Roche
    Sakura Seiki
    Steris
    TSO3


  • Executive Summary
    • OVERVIEW
      • The Nosocomial Infection
        • Table Frequency of the Most Common Nosocomial Infections
    • SCOPE AND METHODOLOGY
    • TOTAL SIZE AND GROWTH OF THE MARKET
      • Table The World Market for Hospital-Acquired Infection Control 2008-2018
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
  • Introduction and Industry Trends
    • OVERVIEW
      • Introduction to Pathogens
      • Classification of Antibacterial Organisms
      • Patient Risk Factors
      • General Infection Statistics
      • Populations at Risk for Infection
        • Table World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2010
    • DEMOGRAPHICS OF THE WORLD
      • Table Estimated World Population by Age and Geographical Region, 2012
      • Life Expectancy
        • Table Average Life Expectancy in Years by Country 1980 and 2012
      • Nosocomial Infection Statistics
      • Common Hospital (nosocomial) Infections
    • INFECTION RISK ASSESSMENTS BY HOSPITAL DEPARTMENT
      • Burn Units
        • Table Burn Statistics
      • Intensive Care Units
      • Emergency Departments
      • Hospital Length of Stay
        • Table U.S. Hospital Length of Stay, Average by Age Group
        • Table Average International Length of Stay, by Country 2010
      • Extended Stay Environments
        • Table U.S. Nursing Homes, Beds, Residents and Occupancy Rate, 2011
        • Table Estimated Nursing Service Establishments and Care Centers by Country
    • ECONOMIC TRENDS
      • Table Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2011
      • Comparison Between Healthcare Spending and Real Health Outcomes
        • Table Healthcare Spending, Obesity and Life Expectancy, 2012
    • U.S. GOVERNMENT'S NATIONAL PLAN TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
      • Steering Committee
      • The American Recovery and Reinvestment Act of 2009
      • Affordable Care Act (ACA) Funding
      • Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Funding
    • U.S. STATEWIDE STANDARDIZED INFECTION RATIO
      • Table U.S. States Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010 to 2011
    • REDUCTION IN HOSPITAL ACQUIRED INFECTIONS
      • Reduction in Infections in Israel
      • Burden of Hospital Acquired Infections
      • Hospital-Acquired Infection Surveillance Process
    • CASE STUDIES
      • Arizona Prevention Study
      • Connecticut Funding for HAI Prevention and Reporting
      • Pennsylvania Study of HAI Admissions and Readmissions
        • Table Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2009
        • Table Pennsylvania State Analysis of HAIs, 2009
    • INFECTIONS AND DRUG RESISTANCE
      • Easing Approvals of Antibiotics
      • Causes of Drug Resistance
      • Drug Resistance in Select Populations
      • Measures for Reducing Resistance
      • Screening Hospitalized patients
    • PHARMACEUTICAL MANUFACTURER AND MARKETER TRENDS
      • Trends in Partnerships and Alliances
      • Developers Trends
  • Infection Prevention
    • OVERVIEW
      • Methods of Transmission
      • High-Risk Facilities or Departments
      • Technology Overview
      • Sterilization vs. Disinfection
      • Equipment and Solutions
      • Heat/Steam Sterilization
      • Chemical Sterilization
      • Radiation Sterilization
        • Table New Developments, Hospital-Acquired Infection Prevention
    • MARKET OVERVIEW
      • Table The World Market for Hospital-Acquired Infection Prevention (Sterilization/Disinfection) 2008-2018
      • Hospital-Acquired Infection Prevention Market by Geographical Region
        • Table The World Market for Hospital-Acquired Infection Prevention (Sterilization/Disinfection) Estimated Products Sales by Primary Geographic Region 2008-2018
    • COMPETITIVE ANALYSIS
      • Table The World Market for Hospital-Acquired Infection Prevention (Sterilization/Disinfection) Leading Suppliers' Shares Estimates for 2013
  • Infection Testing
    • OVERVIEW
      • Drug-Resistance/Susceptibility Testing
      • Genotypic Methods
    • SPECIFIC SERIOUS HOSPITAL-ACQUIRED INFECTION TESTING
      • Acinetobacter Baumannii
      • Clostridium Difficile
      • Hospital-Acquired Pneumonia
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus
      • Tuberculosis
      • Urinary Tract Infections
      • Vancomycin-resistant Enterococcus
      • Ventilator-Associated Pneumonia
        • Table Recent Approvals for Detecting Serious Hospital-Acquired Infections
    • NEW DEVELOPMENTS
      • Table New Developments, Hospital-Acquired Infection Testing, as of July 2013
    • MARKET OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Hospital-Acquired Infection Testing/Diagnostics 2008-2018
      • Hospital-Acquired Infection Testing Market by Geographical Region
        • Table The World Market for Hospital-Acquired Infection Testing/Diagnostics Estimated Products Sales by Primary Geographic Region 2008-2018
    • COMPETITIVE ANALYSIS
      • Table The World Market for Hospital-Acquired Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2013
  • Infection Treatment
    • OVERVIEW
      • Table Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
      • Principles of Anti-bacterial Therapy
    • CLASSIFICATIONS OF ANTIBACTERIAL PRODUCTS
      • Carbapenems
      • Cephalosporins
      • Macrolides
      • Penicillins
      • Quinolones
      • Sulfonamides
      • Tetracyclines
        • Table Antibiotics with Difficult Penetration
    • TREATMENT GUIDELINES
      • Clostridium Difficile
      • Gastroenteritis
      • Hospital-Acquired Pneumonia
      • Ventilator-associated Pneumonia
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus
      • Stenotrophomonas maltophilia
      • Tuberculosis
      • Urinary Tract Infections
    • LEADING PRODUCTS
      • Table Estimated Annual Sales of Select Antibacterial Products 2012
    • NEW DEVELOPMENTS
      • Table New Developments, Hospital-Acquired Infection Treatments, as of July 2013
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Hospital-Acquired Infection Treatment 2008-2018
      • Hospital-Acquired Infection Treatment Market by Geographical Region
        • Table The World Market for Hospital-Acquired Infection Treatment Estimated Products Sales by Primary Geographic Region 2008-2018
    • COMPETITIVE ANALYSIS
      • Table The World Market for Hospital-Acquired Infection Treatment Leading Suppliers 2013
  • Market Opportunities for Hospital-Acquired Infection Control
    • MARKET CONSIDERATIONS
    • MARKET OVERVIEW
      • Table The World Market for Hospital-Acquired Infection Control 2008-2018
      • Hospital-Acquired Infection Control Market by Geographical Region
        • Table The World Market for Hospital-Acquired Infection Control Estimated Products Sales by Primary Geographic Region 2008-2018
  • Company Profiles
    • INTRODUCTION
    • ADVANCED STERILIZATION PRODUCTS
      • Company Performance
    • BECTON, DICKINSON
      • Company Performance
    • BELIMED
      • Company Performance
    • BIOMERIEUX
      • Company Performance
    • CANTEL
      • Company Performance
    • CEPHEID
      • Company Performance
    • GETINGE GROUP
      • Company Performance
    • KIMBERLY-CLARK
      • Company Performance
    • MERCK&CO.
      • Company Performance
    • NORDION
      • Company Performance
    • PFIZER
      • Company Performance
    • ROCHE
      • Company Performance
    • SAKURA SEIKI
    • STERIS
      • Company Performance
    • TSO3
      • Company Performance
  • List of Major Providers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report